Concepedia

Lo Vang

LV

Statistics

Publications

12

Citations

719

H-Index

12

Active since

2009

Affiliations

PaxVax (United States)(Current)

PAX Scientific (United States)

Emergent BioSolutions (United States)

Washington University in St. Louis

La Jolla Institute for Immunology

Lo Vang is an author at PaxVax (United States) specializing in infectious diseases, vaccinology, and life sciences.

ORCID

Publications per year

2009–2023

12

Publications

12

Cryo-EM Structure of Chikungunya Virus in Complex with the Mxra8 Receptor

Katherine Basore, Arthur S. Kim, Christopher A. Nelson et al. · Cell · 2019 · 200 citations · Full text

, , +15

Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope

Arthur S. Kim, Natasha M. Kafai, Emma S. Winkler et al. · Cell · 2021 · 82 citations · Full text

, , +14

Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 Hemagglutinin

Jeff Alexander, Simone Visosky Ward, Jason Mendy et al. · PLoS ONE · 2012 · 64 citations · Full text

, , +17

Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge

Diego A. Espinosa, Jason Mendy, Darly J. Manayani et al. · EBioMedicine · 2017 · 59 citations · Full text

, , +17

Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice

Jeff Alexander, Pamuk Bilsel, Marie‐France del Guercio et al. · Vaccine · 2009 · 52 citations · Full text

, , +17

1–5 of 12